Amro Taha

7PUBLICATIONS
39CO-AUTHORS
Pharmaceutical delivery technologiesCardiology (incl. cardiovascular diseases)Gene and molecular therapyMortalityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

|Jul 15, 2026
GLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis.

|Jun 26, 2026
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

|Oct 28, 2025
COVID-19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity-Matched Cohort Study.

Usman Ali Akbar, Harshith Thyagaturu, Amro Taha

|Oct 11, 2024
Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.

Waqas Ullah, Harigopal Sandhyavenu, Amro Taha

|Jun 06, 2024
Sex and Racial Disparities in Proportionate Mortality of Premature Myocardial Infarction in the United States: 1999 to 2020.

Karthik Gonuguntla, Irisha Badu, Sanchit Duhan

Pageof 2

Frequent Collaborators

3 joint publications

Harshith Thyagaturu

3 joint publications

Haris Bin Tahir

3 joint publications

Muhammad Hassan

3 joint publications

Mohammad Omar Butt